BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Arthur Klausner to participate in the panel "Alternatives for Creating Value in a challenging time" at NASDAQ Healthcare Industry Forum in New York City
News | 12. 08. 2008
